TABLE OF CONTENTS
1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 OVERVIEW OF GLOBAL BREAST RECONSTRUCTION MARKET 26
1.4 CURRENCY AND PRICING 27
1.5 LIMITATIONS 27
1.6 MARKETS COVERED 28
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GLOBAL BREAST RECONSTRUCTION MARKET: GEOGRAPHICAL SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 CURRENCY AND PRICING 32
2.5 RESEARCH METHODOLOGY 33
2.6 DBMR MARKET POSITION GRID 37
2.7 MARKET APPLICATION COVERAGE GRID 38
2.8 DBMR VENDOR SHARE ANALYSIS 39
2.9 MULTIVARIATE MODELING 39
2.10 PRODUCTS LIFELINE CURVE 40
2.11 SECONDARY SOURCES 41
2.12 ASSUMPTIONS 41
3 MARKET OVERVIEW 42
3.1 DRIVERS 44
3.1.1 RISING PREVALENCE & INCIDENCE OF BREAST CANCER 44
3.1.2 INCREASING AESTHETIC APPEARANCE 46
3.1.3 GROWING AWARENESS ABOUT RECONSTRUCTIVE BREAST SURGERIES 46
3.2 RESTRAINTS 47
3.2.1 PRODUCT RECALL 47
3.2.2 HIGH COST OF TREATMENT 48
3.2.3 STRINGENT GOVERNMENT REGULATION 49
3.3 OPPORTUNITIES 50
3.3.1 INNOVATION AND ADVANCEMENT 50
3.3.2 EMERGING MARKETS 51
3.4 CHALLENGE 52
3.4.1 POST-SURGERY COMPLICATION 52
?
4 EXECUTIVE SUMMARY 53
5 PREMIUM INSIGHTS 57
6 GLOBAL BREAST RECONSTRUCTION MARKET, BY TYPE 60
6.1 OVERVIEW 61
6.2 AUTOLOGOUS 62
6.3 ALLOPLASTIC 62
6.3.1 BREAST IMPLANTS 63
6.3.1.1 SILICONE 63
6.3.1.2 SALINE 63
6.3.2 TISSUE EXPANDERS 63
6.3.3 IMPLANTS ACCESSORIES 63
7 GLOBAL BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE 64
7.1 OVERVIEW 65
7.2 ROUND IMPLANT SHAPE 66
7.3 ANATOMICAL IMPLANT SHAPE 66
7.4 ROUND EXPANDER SHAPE 67
7.5 ANATOMICAL EXPANDER SHAPE 67
8 GLOBAL BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY 68
8.1 OVERVIEW 69
8.2 INFRAMAMMARY 70
8.3 TRANS-AXILLARY 70
8.4 PERI-AREOLAR 71
8.5 TRANSUMBILICAL 71
9 GLOBAL BREAST RECONSTRUCTION MARKET, BY PLACEMENT 72
9.1 OVERVIEW 73
9.2 DUAL-PLANE INSERTION 74
9.3 SUBGLANDULAR INSERTION 74
9.4 SUBMUSCULAR INSERTION 75
10 GLOBAL BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL 76
10.1 OVERVIEW 77
10.2 DIRECT TENDERS 78
10.3 RETAIL 78
?
11 GLOBAL BREAST RECONSTRUCTION MARKET, BY END USER 79
11.1 OVERVIEW 80
11.2 HOSPITALS 81
11.3 CLINICS 81
11.4 AMBULATORY SURGICAL CENTERS 82
12 GLOBAL BREAST RECONSTRUCTION MARKET BY GEOGRAPHY 83
12.1 OVERVIEW 84
12.2 NORTH AMERICA 89
12.2.1 U.S. 95
12.2.2 CANADA 97
12.2.3 MEXICO 100
12.3 EUROPE 103
12.3.1 RUSSIA 109
12.3.2 SPAIN 111
12.3.3 ITALY 113
12.3.4 U.K 115
12.3.5 FRANCE 117
12.3.6 GERMANY 119
12.3.7 TURKEY 121
12.3.8 SWITZERLAND 123
12.3.9 NETHERLANDS 125
12.3.10 BELGIUM 127
12.3.11 REST OF EUROPE 129
12.4 ASIA-PACIFIC 130
12.4.1 CHINA 136
12.4.2 JAPAN 138
12.4.3 SOUTH KOREA 140
12.4.4 INDIA 142
12.4.5 AUSTRALIA 144
12.4.6 SINGAPORE 146
12.4.7 MALAYSIA 148
12.4.8 INDONESIA 150
12.4.9 THAILAND 152
12.4.10 PHILIPPINES 154
12.4.11 REST OF ASIA-PACIFIC 156
12.5 SOUTH AMERICA 157
12.5.1 BRAZIL 163
12.5.2 REST OF SOUTH AMERICA 165
?
12.6 MIDDLE EAST AND AFRICA 166
12.6.1 SOUTH AFRICA 172
12.6.2 REST OF MIDDLE EAST AND AFRICA 174
13 GLOBAL BREAST RECONSTRUCTION MARKET, COMPANY LANDSCAPE 175
13.1 COMPANY SHARE ANALYSIS: GLOBAL 175
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 177
13.3 COMPANY SHARE ANALYSIS: EUROPE 178
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 179
14 COMPANY PROFILE 180
14.1 JOHNSON & JOHNSON SERVICES, INC. (MENTOR WORLDWIDE LLC) 180
14.1.1 COMPANY SNAPSHOT 180
14.1.2 REVENUE ANALYSIS 181
14.1.3 COMPANY SHARE ANALYSIS 181
14.1.4 GEOGRAPHICAL PRESENCE 182
14.1.5 PRODUCT PORTFOLIO 182
14.1.6 RECENT DEVELOPMENT 183
14.2 ALLERGAN 184
14.2.1 COMPANY SNAPSHOT 184
14.2.2 REVENUE ANALYSIS 184
14.2.3 COMPANY SHARE ANALYSIS 185
14.2.4 GEOGRAPHICAL PRESENCE 185
14.2.5 PRODUCT PORTFOLIO 186
14.2.6 RECENT DEVELOPMENTS 186
14.3 SIENTRA, INC. 188
14.3.1 COMPANY SNAPSHOT 188
14.3.2 REVENUE ANALYSIS 188
14.3.3 COMPANY SHARE ANALYSIS 189
14.3.4 PRODUCT PORTFOLIO 189
14.3.5 RECENT DEVELOPMENTS 191
14.4 POLYTECH HEALTH & AESTHETICS GMBH 192
14.4.1 COMPANY SNAPSHOT 192
14.4.2 COMPANY SHARE ANALYSIS 192
14.4.3 GEOGRAPHICAL PRESENCE 193
14.4.4 PRODUCT PORTFOLIO 193
14.4.5 RECENT DEVELOPMENTS 195
14.5 AIRXPANDERS, INC. 196
14.5.1 COMPANY SNAPSHOT 196
14.5.2 REVENUE ANALYSIS 196
14.5.3 GEOGRAPHICAL PRESENCE 197
14.5.4 PRODUCT PORTFOLIO 197
14.5.5 RECENT DEVELOPMENTS 198
14.6 ARION LABORATORIES 199
14.6.1 COMPANY SNAPSHOT 199
14.6.2 GEOGRAPHICAL PRESENCE 199
14.6.3 PRODUCT PORTFOLIO 200
14.6.4 RECENT DEVELOPMENTS 200
14.7 CEREPLAS 201
14.7.1 COMPANY SNAPSHOT 201
14.7.2 GEOGRAPHICAL PRESENCE 201
14.7.3 PRODUCT PORTFOLIO 202
14.7.4 RECENT DEVELOPMENTS 203
14.8 ESTABLISHMENT LABS S.A 204
14.8.1 COMPANY SNAPSHOT 204
14.8.2 GEOGRAPHICAL PRESENCE 204
14.8.3 REVENUE ANALYSIS 205
14.8.4 PRODUCT PORTFOLIO 205
14.8.5 RECENT DEVELOPMENTS 206
14.9 GC AESTHETICS 207
14.9.1 COMPANY SNAPSHOT 207
14.9.2 GEOGRAPHICAL PRESENCE 207
14.9.3 PRODUCT PORTFOLIO 208
14.9.4 RECENT DEVELOPMENTS 209
14.10 GROUPE SEBBIN SAS 210
14.10.1 COMPANY SNAPSHOT 210
14.10.2 PRODUCT PORTFOLIO 210
14.10.3 RECENT DEVELOPMENTS 210
14.11 GUANGZHOU WANHE PLASTIC MATERIALS CO., LTD. 211
14.11.1 COMPANY SNAPSHOT 211
14.11.2 GEOGRAPHICAL PRESENCE 211
14.11.3 PRODUCT PORTFOLIO 212
14.11.4 RECENT DEVELOPMENTS 213
14.12 HANSBIOMED CO. LTD 214
14.12.1 COMPANY SNAPSHOT 214
14.12.2 GEOGRAPHICAL PRESENCE 214
14.12.3 PRODUCT PORTFOLIO 215
14.12.4 RECENT DEVELOPMENT 215
?
14.13 IDEAL IMPLANT INCORPORATED 216
14.13.1 COMPANY SNAPSHOT 216
14.13.2 PRODUCT PORTFOLIO 216
14.13.3 RECENT DEVELOPMENT 216
14.14 PMT CORPORATION 217
14.14.1 COMPANY SNAPSHOT 217
14.14.2 GEOGRAPHICAL PRESENCE 217
14.14.3 PRODUCT PORTFOLIO 218
14.14.4 RECENT DEVELOPMENTS 219
14.15 SHANGHAI KANGNING MEDICAL SUPPLIES LTD 220
14.15.1 COMPANY SNAPSHOT 220
14.15.2 PRODUCT PORTFOLIO 221
14.15.3 RECENT DEVELOPMENTS 221
15 QUESTIONNAIRE 222
16 RELATED REPORTS 225